Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Study aims to improve shared Decision-Making in metastatic breast cancer

NCT ID NCT03248258

First seen Feb 28, 2026 · Last updated Jun 23, 2026 · Updated 12 times

Summary

This completed study from the University of Alabama at Birmingham involved 200 women with metastatic or early-stage breast cancer. Researchers conducted interviews and focus groups with patients, nurses, and doctors to understand how treatment decisions are made, including the option to reduce chemotherapy. The goal was to develop an electronic treatment plan that supports shared decision-making, where patients' values and preferences are considered alongside medical advice.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DECISION MAKING ,SHARED are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • University of Alabama at Birmingham

    Birmingham, Alabama, 35249, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better communication tools that help patients and doctors make treatment choices together, improving quality of care.

What could go wrong

This is a small, qualitative study that does not test a treatment. The findings may not apply to all patients or settings.

Conditions

The condition(s) this trial relates to.

breast neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.